Skip to main content
×
Home
    • Aa
    • Aa

Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History

  • Kathryn N. Devlin (a1), Assawin Gongvatana (a1) (a2), Uraina S. Clark (a1) (a2), Jesse D. Chasman (a1) (a2), Michelle L. Westbrook (a1) (a3), Karen T. Tashima (a3) (a4), Bradford Navia (a5) and Ronald A. Cohen (a1) (a2)...
Abstract
Abstract

HIV-associated neurocognitive dysfunction persists in the highly active antiretroviral therapy (HAART) era and may be exacerbated by comorbidities, including substance use and hepatitis C virus (HCV) infection. However, the neurocognitive impact of HIV, HCV, and substance use in the HAART era is still not well understood. In the current study, 115 HIV-infected and 72 HIV-seronegative individuals with significant rates of lifetime substance dependence and HCV infection received comprehensive neuropsychological assessment. We examined the effects of HIV serostatus, HCV infection, and substance use history on neurocognitive functioning. We also examined relationships between HIV disease measures (current and nadir CD4, HIV RNA, duration of infection) and cognitive functioning. Approximately half of HIV-infected participants exhibited neurocognitive impairment. Detectable HIV RNA but not HIV serostatus was significantly associated with cognitive functioning. HCV was among the factors most consistently associated with poorer neurocognitive performance across domains, while substance use was less strongly associated with cognitive performance. The results suggest that neurocognitive impairment continues to occur in HIV-infected individuals in association with poor virologic control and comorbid conditions, particularly HCV coinfection. (JINS, 2012, 18, 68–78)

Copyright
Corresponding author
Correspondence and reprint requests to: Ronald A. Cohen, Centers for Behavioral & Preventive Medicine, Coro Building, Suite 314, One Hoppin Street, Providence, RI 02903. E-mail: rcohen@lifespan.org
References
Hide All
Ances B.M., Vaida F., Yeh M.J., Liang C.L., Buxton R.B., Letendre S., Ellis R.J. (2010). HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. Journal of Infectious Diseases, 201(3), 336340.
Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., Alter M.J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705714.
Bajaj J.S., Wade J.B., Sanyal A.J. (2009). Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology, 50(6), 20142021.
Basso M.R., Bornstein R.A. (2000). Neurobehavioural consequences of substance abuse and HIV infection. Journal of Psychopharmacology, 14(3), 228237.
Benedict R.H.B. (1997). Brief Visuospatial Memory Test - Revised. Odessa, FL: Psychological Assessment Resources.
Benedict R.H.B., Schretlen A., Groninger L., Brandt J. (1998). Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 4355.
Benedict R.H.B., Schretlen D., Groninger L., Dobraski M., Shpritz B. (1996). Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychological Assessment, 8(2), 145153.
Benton A.L., Hamsher K., Sivan A.B. (1994). Multilingual Aphasia Examination. Iowa City: AJA Associates.
Bica I., McGovern B., Dhar R., Stone D., McGowan K., Scheib R., Snydman D.R. (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 32(3), 492497.
Bornstein R.A., Nasrallah H.A., Para M.F., Whitacre C.C., Fass R.J. (1994). Duration of illness and neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 6(2), 160164.
Brandt J., Benedict R.H.B. (1991). Hopkins Verbal Learning Test-Revised (HVLT-R). Lutz, FL: Psychological Assessment Resources, Inc.
Brew B.J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(Suppl. 1), S75S78.
Brew B.J., Crowe S.M., Landay A., Cysique L.A., Guillemin G. (2009). Neurodegeneration and ageing in the HAART era. Journal of Neuroimmune Pharmacology, 4(2), 163174.
Brown T.T., Cole S.R., Li X., Kingsley L.A., Palella F.J., Riddler S.A., Dobs A.S. (2005). Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine, 165(10), 11791184.
Carey C.L., Woods S.P., Gonzalez R., Conover E., Marcotte T.D., Grant I., Heaton R.K. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307319.
Carrat F., Bani-Sadr F., Pol S., Rosenthal E., Lunel-Fabiani F., Benzekri A., Perronne C. (2004). Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. JAMA, 292(23), 28392848.
Chang L., Ernst T., Witt M.D., Ames N., Gaiefsky M., Miller E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage, 17(3), 16381648.
Chen Y., An H., Zhu H., Stone T., Smith J.K., Hall C., Lin W. (2009). White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage, 47(4), 11541162.
Cherner M., Ellis R.J., Lazzaretto D., Young C., Mindt M.R., Atkinson J.H., Heaton R.K. (2004). Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS, 18(Suppl. 1), S27S34.
Cherner M., Letendre S., Heaton R.K., Durelle J., Marquie-Beck J., Gragg B., Grant I. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 13431347.
Childs E.A., Lyles R.H., Selnes O.A., Chen B., Miller E.N., Cohen B.A., McArthur J.C. (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52(3), 607613.
Chung R.T., Andersen J., Volberding P., Robbins G.K., Liu T., Sherman K.E., van der Horst C. (2004). Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine, 351(5), 451459.
Clifford D.B. (2008). HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV Medicine, 16(2), 9498.
Clifford D.B., Evans S.R., Yang Y., Gulick R.M. (2005). The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS, 19(Suppl. 3), S64S71.
Clifford D.B., Smurzynski M., Park L.S., Yeh T.M., Zhao Y., Blair L., Evans S.R. (2009). Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology, 73(4), 309314.
Cohen R.A., Boland R., Paul R., Tashima K.T., Schoenbaum E.E., Celentano D.D., Carpenter C.C. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15(3), 341345.
Cohen R.A., de la Monte S., Gongvatana A., Ombao H., Gonzalez B., Devlin K.N., Tashima K.T. (2011). Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. Journal of Neuroimmunology, 233(1–2), 204210.
Cohen R.A., Harezlak J., Gongvatana A., Buchthal S., Schifitto G., Clark U., Navia B. (2010). Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of Neurovirology, 16(6), 435444.
Cohen R.A., Harezlak J., Schifitto G., Hana G., Clark U., Gongvatana A., Navia B. (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology, 16(1), 2532.
Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566576.
Crum N.F., Riffenburgh R.H., Wegner S., Agan B.K., Tasker S.A., Spooner K.M., Wallace M.R. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41(2), 194200.
Cysique L.A., Maruff P., Brew B.J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 14471450.
Cysique L.A., Vaida F., Letendre S., Gibson S., Cherner M., Woods S.P., Ellis R.J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342348.
Davis P.E., Liddiard H., McMillan T.M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67(1), 105108.
de la Monte S.M., Longato L., Tong M., DeNucci S., Wands J.R. (2009). The liver-brain axis of alcohol-mediated neurodegeneration: Role of toxic lipids. International Journal of Environmental Research and Public Health, 6(7), 20552075.
de la Monte S.M., Tong M., Nguyen V., Setshedi M., Longato L., Wands J.R. (2010). Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. Journal of Alzheimer's Disease, 21(3), 967984.
Deeks S.G., Phillips A.N. (2009). HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ (Clinical Research Ed.), 338, a3172.
Di Sclafani V., Tolou-Shams M., Price L.J., Fein G. (2002). Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug and Alcohol Dependence, 66(2), 161171.
Eldreth D.A., Matochik J.A., Cadet J.L., Bolla K.I. (2004). Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage, 23(3), 914920.
Ellis R., Langford D., Masliah E. (2007). HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nature Reviews. Neuroscience, 8(1), 3344.
Ersche K.D., Clark L., London M., Robbins T.W., Sahakian B.J. (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31(5), 10361047.
Fals-Stewart W., Schafer J., Lucente S., Rustine T., Brown L. (1994). Neurobehavioral consequences of prolonged alcohol and substance abuse: A review of findings and treatment implications. Clinical Psychology Review, 14(8), 755778.
Fein G., Torres J., Price L.J., Di Sclafani V. (2006). Cognitive performance in long-term abstinent alcoholic individuals. Alcoholism, Clinical and Experimental Research, 30(9), 15381544.
Fernandez-Serrano M.J., Perez-Garcia M., Schmidt Rio-Valle J., Verdejo-Garcia A. (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of Psychopharmacology, 24(9), 13171332.
Fernandez-Serrano M.J., Perez-Garcia M., Verdejo-Garcia A. (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35(3), 377406.
Forton D.M., Allsop J.M., Cox I.J., Hamilton G., Wesnes K., Thomas H.C., Taylor-Robinson S.D. (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, 19(Suppl. 3), S53S63.
Forton D.M., Allsop J.M., Main J., Foster G.R., Thomas H.C., Taylor-Robinson S.D. (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet, 358(9275), 3839.
Forton D.M., Thomas H.C., Murphy C.A., Allsop J.M., Foster G.R., Main J., Taylor-Robinson S.D. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35(2), 433439.
Golden C.J. (1978). Stroop Color and Word Test. Chicago: Stoelting.
Gongvatana A., Cohen R.A., Correia S., Devlin K.N., Miles J., Clark U.S., Tashima K.T. (2011, February). Impact of Hepatitis C and HIV coinfection on cerebral white matter integrity. Proceedings of the 39th Annual Meeting of the International Neuropsychological Society, Boston, MA.
Gongvatana A., Schweinsburg B.C., Taylor M.J., Theilmann R.J., Letendre S.L., Alhassoon O.M., Grant I. (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. Journal of Neurovirology, 15(2), 187195.
Grant B.F. (1996). Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse, 8(2), 195210.
Green J.E., Saveanu R.V., Bornstein R.A. (2004). The effect of previous alcohol abuse on cognitive function in HIV infection. American Journal of Psychiatry, 161(2), 249254.
Gruber S.A., Silveri M.M., Yurgelun-Todd D.A. (2007). Neuropsychological consequences of opiate use. Neuropsychology Review, 17(3), 299315.
Harezlak J., Buchthal S., Taylor M., Schifitto G., Zhong J., Daar E., Navia B. (2011). Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS, 25(5), 625633.
Hasin D.S., Stinson F.S., Ogburn E., Grant B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830842.
Heaton R.K., Clifford D.B., Franklin D.R. Jr., Woods S.P., Ake C., Vaida F., Grant I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 20872096.
Heaton R.K., Grant I., Butters N., White D.A., Kirson D., Atkinson J.H., … the HNRC Group. (1995). The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 1(3), 231251.
Heaton R.K., Miller W., Taylor M., Grant I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
Hesselink J.R., Tien R., Spoto G., Jernigan T.L., Grant I. (1991, June). Accelerated brain atrophy and parenchymal change in patients with AIDS. Proceedings of the International Conference on AIDS, Florence, Italy.
Hilsabeck R.C., Castellon S.A., Hinkin C.H. (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41(Suppl. 1), S38S44.
Hilsabeck R.C., Perry W., Hassanein T.I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35(2), 440446.
Hinkin C.H., Castellon S.A., Levine A.J., Barclay T.R., Singer E.J. (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. Journal of Addictive Diseases, 27(2), 1117.
Janssen R.S., Saykin A.J., Cannon L., Campbell J., Pinsky P.F., Hessol N.A., Kaplan J.E. (1989). Neurological and neuropsychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection. Annals of Neurology, 26(5), 592600.
Jernigan T.L., Archibald S., Hesselink J.R., Atkinson J.H., Velin R.A., McCutchan J.A., Grant I. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Archives of Neurology, 50(3), 250255.
Kellogg S.H., McHugh P.F., Bell K., Schluger J.H., Schluger R.P., LaForge K.S., Kreek M.J. (2003). The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence, 69(2), 137150.
Kim W.R. (2002). The burden of hepatitis C in the United States. Hepatology, 36(5 Suppl. 1), S30S34.
Kløve H. (1963). Grooved pegboard. Lafayette, IN: Lafayette Instruments.
Kramer L., Bauer E., Funk G., Hofer H., Jessner W., Steindl-Munda P., Ferenci P. (2002). Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology, 37(3), 349354.
Laskus T., Radkowski M., Bednarska A., Wilkinson J., Adair D., Nowicki M., Rakela J. (2002). Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. Journal of Virology, 76(19), 1006410068.
Letendre S.L., McCutchan J.A., Childers M.E., Woods S.P., Lazzaretto D., Heaton R.K., Ellis R.J. (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology, 56(3), 416423.
Letendre S.L., Paulino A.D., Rockenstein E., Adame A., Crews L., Cherner M., Masliah E. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196(3), 361370.
Lundqvist T. (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology, Biochemistry and Behavior, 81(2), 319330.
Martin-Thormeyer E.M., Paul R.H. (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: Neurocognitive and neuroimaging features. Neuropsychology Review, 19(2), 215231.
McArthur J.C. (2004). HIV dementia: An evolving disease. Journal of Neuroimmunology, 157(1–2), 310.
McArthur J.C., McClernon D.R., Cronin M.F., Nance-Sproson T.E., Saah A.J., St Clair M., Lanier E.R. (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology, 42(5), 689698.
McCrea M., Cordoba J., Vessey G., Blei A.T., Randolph C. (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology, 53(8), 758763.
McCutchan J.A., Wu J.W., Robertson K., Koletar S.L., Ellis R.J., Cohn S., Williams P.L. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 11091117.
Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., d'Arminio Monforte A., Lundgren J.D. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377), 2229.
Monga H.K., Rodriguez-Barradas M.C., Breaux K., Khattak K., Troisi C.L., Velez M., Yoffe B. (2001). Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 33(2), 240247.
Moore D.J., Masliah E., Rippeth J.D., Gonzalez R., Carey C.L., Cherner M., Grant I. (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS, 20(6), 879887.
Morgello S., Estanislao L., Ryan E., Gerits P., Simpson D., Verma S., Sharp V. (2005). Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS, 19(Suppl. 3), S116S122.
Nath A., Maragos W.F., Avison M.J., Schmitt F.A., Berger J.R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology, 7(1), 6671.
O'Malley S., Adamse M., Heaton R.K., Gawin F.H. (1992). Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse, 18(2), 131144.
Obel N., Thomsen H.F., Kronborg G., Larsen C.S., Hildebrandt P.R., Sorensen H.T., Gerstoft J. (2007). Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A population-based cohort study. Clinical Infectious Diseases, 44(12), 16251631.
Palella F.J. Jr., Baker R.K., Moorman A.C., Chmiel J.S., Wood K.C., Brooks J.T., Holmberg S.D. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43(1), 2734.
Pascual-Leone A., Dhuna A., Anderson D.C. (1991). Longterm neurological complications of chronic, habitual cocaine abuse. Neurotoxicology, 12(3), 393400.
Paul R.H., Ernst T., Brickman A.M., Yiannoutsos C.T., Tate D.F., Cohen R.A., Navia B.A. (2008). Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. Journal of the International Neuropsychological Society, 14(5), 725733.
Paul R.H., Yiannoutsos C.T., Miller E.N., Chang L., Marra C.M., Schifitto G., Navia B.A. (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: Evidence of subcortical specificity. Journal of Neuropsychiatry and Clinical Neurosciences, 19(3), 283292.
Perry W., Hilsabeck R.C., Hassanein T.I. (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases and Sciences, 53(2), 307321.
Pezawas L.M., Fischer G., Diamant K., Schneider C., Schindler S.D., Thurnher M., Kasper S. (1998). Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements. Psychiatry Research, 83(3), 139147.
Phillips A.N., Neaton J., Lundgren J.D. (2008). The role of HIV in serious diseases other than AIDS. AIDS, 22(18), 24092418.
Pomara N., Crandall D.T., Choi S.J., Johnson G., Lim K.O. (2001). White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study. Psychiatry Research, 106(1), 1524.
Powles T., Robinson D., Stebbing J., Shamash J., Nelson M., Gazzard B., Bower M. (2009). Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. Journal of Clinical Oncology, 27(6), 884890.
Radloff L.S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385401.
Reitan R.M. (1992). Trail Making Test. Tucson, AZ: Reitan Neuropsychology Laboratory.
Rippeth J.D., Heaton R.K., Carey C.L., Marcotte T.D., Moore D.J., Gonzalez R., Grant I. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 114.
Robertson K.R., Robertson W.T., Ford S., Watson D., Fiscus S., Harp A.G., Hall C.D. (2004). Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndromes, 36(1), 562566.
Robertson K.R., Smurzynski M., Parsons T.D., Wu K., Bosch R.J., Wu J., Ellis R.J. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 19151921.
Ryan E.L., Morgello S., Isaacs K., Naseer M., Gerits P. (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62(6), 957962.
Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., Epstein L. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8(2), 136142.
Sherman K.E., Rouster S.D., Chung R.T., Rajicic N. (2002). Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 34(6), 831837.
Stern R.A., Arruda J.E., Somerville J.A., Cohen R.A., Boland R.J., Stein M.D., Martin E.M. (1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4(2), 172178.
Stoff D.M. (2004). Mental health research in HIV/AIDS and aging: Problems and prospects. AIDS, 18(Suppl. 1), S3S10.
Tarter R.E., Hegedus A.M., Van Thiel D.H., Schade R.R., Gavaler J.S., Starzl T.E. (1984). Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology, 86(6), 14211427.
Thompson P.M., Dutton R.A., Hayashi K.M., Toga A.W., Lopez O.L., Aizenstein H.J., Becker J.T. (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 1564715652.
Tozzi V., Balestra P., Bellagamba R., Corpolongo A., Salvatori M.F., Visco-Comandini U., Narciso P. (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: Prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes, 45(2), 174182.
Tozzi V., Balestra P., Lorenzini P., Bellagamba R., Galgani S., Corpolongo A., Narciso P. (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11(3), 265273.
Valcour V.G., Shikuma C.M., Watters M.R., Sacktor N.C. (2004). Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. AIDS, 18(Suppl. 1), S79S86.
Valcour V.G., Yee P., Williams A.E., Shiramizu B., Watters M., Selnes O., Sacktor N. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12(5), 387391.
van Gorp W.G., Wilkins J.N., Hinkin C.H., Moore L.H., Hull J., Horner M.D., Plotkin D. (1999). Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry, 56(1), 8589.
Weber R., Sabin C.A., Friis-Moller N., Reiss P., El-Sadr W.M., Kirk O., Lundgren J.D. (2006). Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Archives of Internal Medicine, 166(15), 16321641.
Wechsler D. (1997). Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: The Psychological Corporation.
Weissenborn K., Krause J., Bokemeyer M., Hecker H., Schuler A., Ennen J.C., Boker K.W. (2004). Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41(5), 845851.
Wilkinson J., Radkowski M., Laskus T. (2009). Hepatitis C virus neuroinvasion: Identification of infected cells. Journal of Virology, 83(3), 13121319.
Woods S.P., Moore D.J., Weber E., Grant I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152168.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 22 *
Loading metrics...

Abstract views

Total abstract views: 166 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.